Comparison between Earum Pharmaceuticals IPO and SBC Exports IPO.
Earum Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while SBC Exports IPO is a SME Fixed Price proposed to list at BSE SME.
| Earum Pharmaceuticals IPO | SBC Exports IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Hem Securities Ltd. | Navigant Corporate Advisors Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Hem Securities Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the SBC Exports IPO is up to ₹6.23 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of SBC Exports IPO is ₹22.00 per share.
| Earum Pharmaceuticals IPO | SBC Exports IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹36.00 per share | ₹22.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 6000 shares |
| Fresh Issue Size | 17,52,000 shares | 28,32,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.31 Cr | up to ₹6.23 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,52,000 shares | 28,32,000 shares |
| Issue Size Total (Amount) | up to ₹6.31 Cr | up to ₹6.23 Cr |
Earum Pharmaceuticals IPO opens on Jun 21, 2019, while SBC Exports IPO opens on Jun 24, 2019. The closing date of Earum Pharmaceuticals IPO and SBC Exports IPO is Jun 26, 2019, and Jun 26, 2019, respectively.
| Earum Pharmaceuticals IPO | SBC Exports IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 21, 2019 | Jun 24, 2019 |
| Issue Close | Jun 26, 2019 | Jun 26, 2019 |
| Basis Of Allotment (Tentative) | Jul 01, 2019 | Jul 01, 2019 |
| Initiation of Refunds (Tentative) | Jul 02, 2019 | Jul 02, 2019 |
| Credit of Share (Tentative) | Jul 03, 2019 | Jul 03, 2019 |
| Listing date (Tentative) | Jul 04, 2019 | Jul 04, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Earum Pharmaceuticals IPO P/E ratio is , as compared to SBC Exports IPO P/E ratio of .
| Earum Pharmaceuticals IPO | SBC Exports IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 92.91 | ||||
| Promoter Shareholding (Post-Issue) | 70.04 | 66.73 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹22.20 Cr. | ₹23.28 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in SBC Exports IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in SBC Exports IPO.
| Earum Pharmaceuticals IPO | SBC Exports IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 96,000 shares | 1,50,000 shares |
| QIB | ||
| NII | 8,76,000 shares | 14,16,000 shares |
| RII | 8,76,000 shares | 14,16,000 shares |
| Employee | ||
| Others | ||
| Total | 17,52,000 shares | 28,32,000 shares |
Earum Pharmaceuticals IPO subscribed 1.60x in total, whereas SBC Exports IPO subscribed 1.36x.
| Earum Pharmaceuticals IPO | SBC Exports IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.72x | 1.94x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.48x | 0.78x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.60x | 1.36x |
